Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2

4(50.0%)

Phase 1

4(50.0%)

8Total

Phase 2(4)

Phase 1(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT07571928Phase 1Not Yet Recruiting

A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia

Role: lead

NCT06706414Phase 1Active Not Recruiting

NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia

Role: lead

NCT07254429Phase 2Recruiting

COMPASS - COpenhagen MenoPAuSe Study

Role: lead

NCT06300229Phase 1Completed

NAPO - Novel Approach for Oligospermia

Role: lead

NCT04292288Recruiting

Hypercalcemia After Paraffin Oil Injection

Role: lead

NCT03254641Completed

Calciotropic Effects After HCG Stimulation Test

Role: lead

NCT05212337Phase 2Active Not Recruiting

FITMI - First In Treating Male Infertility

Role: lead

NCT03030196Phase 2Completed

Denosumab and Male Infertility: a RCT

Role: lead

NCT03418896Phase 1Completed

Extragonadal Effects of hCG on Calcium Homeostasis

Role: lead

NCT02422108Phase 2Completed

TNFSF11 Inhibition and Fertility: a Prospective Study

Role: lead

NCT02437578Completed

Clinical Tests to Predict the Success of Assisted Reproductive Techniques

Role: lead

All 11 trials loaded